OpenVSafe by OpenVAERS
Search V-safe

RUZ-48424-44404

2 vaccinations 1 coded response 14 check-ins 1 free-text entry 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
970 / OR
Registered
2021-01-12
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
1026915 (opens in a new window) high 8 / 11 2 0 of 10 VAERS symptoms same dose (2) OR matches 2021-01-12 / 2021-01-12 / 2021-02-12
received the same day as the last call
case 147363

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2020-12-21
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-12
    Registered in v-safe
  3. 2021-01-12
    Dose 2 — Pfizer-BioNTech
  4. 2021-01-12
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  5. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-01-13
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  7. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  8. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-01-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-01-19
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-01-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-02-02
    Survey response — day 21, dose 2
    MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work
    Free text: Mild cold symptoms
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-02-02
    Report sent to call center — day 21, dose 2
    Be unable to work
    1 call case(s)
  15. 2021-02-09
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-02-12
    Call successful
    Completed over the phone
  17. 2021-02-18
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-02-23
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-07-13
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2022-01-12
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-21Pfizer-BioNTech
22021-01-12Pfizer-BioNTech

Call center

2 call center cases

2 successful

VAERS report filed, before or during a call: 2

See the call center timeline

Free text

Release 3 — day 21, dose 2

2021-02-02

Symptoms: Mild cold symptoms

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasopharyngitis ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release